Our work indicates, for the first time, the possible phosphorylation of ULK1 on its serine757 inhibitory residue by RAF1, which opens up a new therapeutic avenue to modulate the autophagy flux in ALK+ ALCL. Here, ULK1 is linked to anaplastic large cell lymphoma.